With the acquisition, Datwyler has expanded its reach to eight facilities across China, India, Italy, Germany, Belgium, and the USA
Datwyler has completed its acquisition of Chinese pharma packaging company, Yantai Xinhui Packing. Located in Shandong, Xinhui manufactures elastomer components including isoprene rubber discs, which Datwyler says complement its current portfolio of packaging and medical products. The acquisition is aimed to help Swiss-headquartered company strengthen local production and customer support for manufacturers in China.
The company plans to invest in an expansion of Xinhui’s production capacity, and will later announce which products from its current portfolio will be manufactured for the Chinese market.
The current plant generates annual revenue of $16m, but Datwyler anticipates production could double through the activation of spare capacity within the plant’s existing footprint.
“China’s growing middle class and expectations for 10 percent annual growth YOY in applicable healthcare markets make the country a strategically important addition to our global network,” said Dirk Borghs, CEO of Datwyler Healthcare Solutions. “We are proud to welcome Xinhui's 170 employees into our family. Together, Datwyler and Xinhui can create an optimal platform for local production and marketing of a wide and competitive product range.”
“For nearly 20 years, Xinhui has manufactured high-quality elastomer components for critical healthcare applications,” said Liu Xinsheng, Chairman of Yantai Xinhui Packing. “Datwyler’s shared commitment to quality, sophisticated manufacturing principles, and a collaborative environment made the company an ideal fit for our dedicated workforce to continue to serve China’s demanding healthcare market.”
With the acquisition, Datwyler has expanded its reach to eight facilities across China, India, Italy, Germany, Belgium, and the USA.